
A Duke materials scientist turned one stubborn laboratory technique into a biotech company, a Novartis collaboration, and a practical lesson in building around the minutes people want back.
Deborah Bitterfield raised about $8 million over seven years to prove that a protein could be dried into microbeads and shot through a needle. Then Novartis signed a deal worth up to nearly $1 billion.